Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:person
|
| gptkbp:birthDate |
1924-02-22
|
| gptkbp:birthPlace |
gptkb:Markinch,_Fife,_Scotland
|
| gptkbp:deathDate |
2011-11-08
|
| gptkbp:deathPlace |
gptkb:United_Kingdom
|
| gptkbp:education |
gptkb:University_of_Glasgow
|
| gptkbp:employer |
gptkb:Glaxo
|
| gptkbp:field |
gptkb:medicine
gptkb:pharmacy |
| gptkbp:honor |
gptkb:Fellow_of_the_Royal_Society
gptkb:order_of_merit |
| https://www.w3.org/2000/01/rdf-schema#label |
Sir David Jack
|
| gptkbp:knownFor |
drug discovery
|
| gptkbp:nationality |
British
|
| gptkbp:notableWork |
development of beclometasone
development of ranitidine development of salbutamol development of salmeterol |
| gptkbp:occupation |
gptkb:pharmacy
gptkb:researchers |
| gptkbp:positionHeld |
Research Director at Glaxo
|
| gptkbp:spouse |
Margaret Jack
|
| gptkbp:bfsParent |
gptkb:GLAXO
|
| gptkbp:bfsLayer |
7
|